Final overall survival results of the IDEA Collaboration: 3 vs 6 months of adjuvant chemotherapy for Stage III Colon Cancer

Final Overall Survival Results of the IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Stage III Colon Cancer – The ASCO Post

Original article: Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials – The Lancet Oncology (link to abstract – $ for full-text)

Commentary on Twitter

Prospective analysis of 6 phase III trials on stage III colon cancer did not confirm non-inferior OS with 3 vs 6 months of adjuvant chemotherapy: the absolute difference in 5-yr OS was 0.4%, but reduced toxicities, inconvenience & costs may be important: https://t.co/mMjyRjeWyM

— NatureRevClinOncol (@NatRevClinOncol) December 2, 2020